Redburn
Qize Ding, Ph.D has a diverse work experience spanning several companies and roles. Qize is currently employed at Redburn as an Equity Research Analyst since August 2022. Prior to that, they worked at Jefferies as a Senior Analyst in Healthcare Investment Banking from 2021 to 2022. Qize also worked at PharmaVentures as an Associate Director from 2019 to 2021 and at Citi as a Senior Associate in Equity Research from 2017 to 2019. Qize served as a Scientist at Adaptimmune from 2015 to 2017 and as an Assistant Research Scientist at the University of Oxford from 2010 to 2012.
Qize Ding, Ph.D has pursued a Doctor of Philosophy degree in Cancer Biology with a focus on Targeted cancer therapy at Imperial College London. This educational journey was financially supported by a full scholarship. In addition to their academic achievements, Qize Ding is also a Level 3 candidate for the Chartered Financial Analyst (CFA) certification, offered by the CFA Institute.